ATE443520T1 - Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung - Google Patents

Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung

Info

Publication number
ATE443520T1
ATE443520T1 AT03724735T AT03724735T ATE443520T1 AT E443520 T1 ATE443520 T1 AT E443520T1 AT 03724735 T AT03724735 T AT 03724735T AT 03724735 T AT03724735 T AT 03724735T AT E443520 T1 ATE443520 T1 AT E443520T1
Authority
AT
Austria
Prior art keywords
compositions containing
cancer treatment
hepoxilin analogs
hepoxilin
analogs
Prior art date
Application number
AT03724735T
Other languages
English (en)
Inventor
Cecil Pace-Asciak
Original Assignee
Pace Asciak Cecil R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pace Asciak Cecil R filed Critical Pace Asciak Cecil R
Application granted granted Critical
Publication of ATE443520T1 publication Critical patent/ATE443520T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03724735T 2002-05-28 2003-05-28 Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung ATE443520T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38313402P 2002-05-28 2002-05-28
PCT/CA2003/000780 WO2003099285A1 (en) 2002-05-28 2003-05-28 Compositions comprising hepoxilin analogs and their use in the treatment of cancer

Publications (1)

Publication Number Publication Date
ATE443520T1 true ATE443520T1 (de) 2009-10-15

Family

ID=29584512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724735T ATE443520T1 (de) 2002-05-28 2003-05-28 Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung

Country Status (7)

Country Link
US (1) US7666905B2 (de)
EP (1) EP1509229B1 (de)
AT (1) ATE443520T1 (de)
AU (1) AU2003229202A1 (de)
CA (1) CA2526943C (de)
DE (1) DE60329386D1 (de)
WO (1) WO2003099285A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2427774C (en) 2000-11-09 2013-01-15 The Hospital For Sick Children Inhibitors of thromboxane formation and action
US7943586B2 (en) 2003-06-09 2011-05-17 The Trustees Of The University Of Pennsylvania Antineoplastic agents targeted via glut transporters
WO2006106438A2 (en) * 2005-01-11 2006-10-12 Evolva Sa Modulators of ppar activity
US8710252B2 (en) 2006-04-19 2014-04-29 Cecil Pace-Asciak Hepodxilin analog enantiomers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022848A1 (en) 1993-03-29 1994-10-13 Pace Asciak Cecil R Hepoxilin analogs useful as anti-inflammatory agents
US5789441A (en) * 1996-02-15 1998-08-04 Virocell Inc. Leukotriene B4 as an antiviral and anti-neoplastic agent
US6391305B1 (en) * 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
IL139307A0 (en) * 1998-05-19 2001-11-25 Res Dev Foundation Triterpene compositions and methods for use thereof
CA2393904C (en) 1999-08-04 2012-10-16 Hsc Research And Development Limited Partnership Hepoxilin analogs
CA2427774C (en) * 2000-11-09 2013-01-15 The Hospital For Sick Children Inhibitors of thromboxane formation and action

Also Published As

Publication number Publication date
EP1509229A1 (de) 2005-03-02
CA2526943C (en) 2011-08-09
EP1509229B1 (de) 2009-09-23
AU2003229202A1 (en) 2003-12-12
WO2003099285A1 (en) 2003-12-04
US7666905B2 (en) 2010-02-23
DE60329386D1 (de) 2009-11-05
US20050272671A1 (en) 2005-12-08
CA2526943A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
ATE435199T1 (de) Diarylharnstoffderivate und deren verwendung als chloridkanalblocker
GEP20104994B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
UY26981A1 (es) Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
SV1999000047A (es) Nuevas dihidropirimidinas fef. lea 32792-sv
BRPI0416692A (pt) inibidores heterocìclicos de mek e métodos de emprego destes
UY29246A1 (es) Nuevos compuestos
PA8550101A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células, y métodos para su utilización
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
DE60045508D1 (de) Dalda-analoge und ihre verwendung
DE602004024213D1 (en) Aminopropanolderivate
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
ATE452896T1 (de) C3-cyanoepothilonderivate
ATE499098T1 (de) Verwendung von parp-1-hemmern
NO20043792L (no) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
IL178727A0 (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
TW200626527A (en) Novel hexafluoroisopropanol derivatives
DE60322064D1 (de) 4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen
DE602007010430D1 (de) Camptothecinderivate und ihre verwendung
DE60329386D1 (de) Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung
SE0300457D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties